Back to search

University of Crete (UOC)

Ο ρόλος του ενδογενούς συστήματος των κανναβινοειδών στη συμπεριφορά και στους μηχανισμούς ανταμοιβής: πειραματική μελέτη σε επιμύες

Abstract

dc:description

In the past few years, there has been a tremendous increase in the number of studies conducted focusing on the endogenous cannabinoid system. These studies have shown that cannabinoids produce numerous therapeutic actions and have led to the approval of some cannabinoid agents for therapeutic purposes. However, due to their possible addictive effects, even today the scientific community seems to be divided regarding the therapeutic development of cannabis and its analogs. Drugs that have euphorigenic effects in humans have been shown to have reinforcing effects in animal experimental models. Also, apart from their addictive and rewarding effects, they seem to stimulate locomotor activity. Nevertheless, it has been difficult to show the rewarding effects of cannabis, and its main psychoactive constituent Δ9-tetrahydrocannabinol (Δ9-THC), the CB1 cannabinoid receptor agonists, as well as different endocannabinoid modulators in the experimental animal models used to study the rewarding actions and the addictive effects of psychotropic drugs. The main question of the present study was the investigation of specific cannabinoids (Δ9-THC, selective agonists of the CB1 receptor and modulators of endocannabinoids) on reward and behaviour of experimental animals to test whether these substances possess rewarding effects and in which way they impact upon locomotion. A further purpose of the study was to clarify the role of endogenous cannabinoids and their CB1 receptors on these behaviours. More specifically, the rewarding effects of cannabinoids were accessed by using the dose-response curve of the intracranial self-stimulation paradigm (ICSS) and the motor effects were accessed by using automatic locomotor activity cages. The results of the present study show that Δ9-THC does not have rewarding effects in any of the doses tested. On the contrary, in high doses it causes significant increase of the self-stimulation threshold, which means that it decreases the rewarding effect of the lateral hypothalamus stimulation. This effect is probably mediated through CB1 receptor stimulation. Moreover, selective CB1 receptor agonists do not affect the rewarding efficacy of the self-stimulation in low doses (WIN 55,212-2, CP 55,940 and HU-210), while high doses have an inhibitory effect on reward and either do not affect or decrease the asymptotic rate of responding. Their effect is also probably mediated through CB1 receptor stimulation. Additionally, the intraperitoneal injection of endocannabinoid modulators (ΑΜ-404, PMSF, URB-597 και OMDM-2) either does not affect or increases the self-stimulation threshold by reducing the rewarding efficacy of the stimulation, depending on the dose administered. These results may be attributed to direct or indirect simulation of the CB1 receptor. Most of the doses tested do not affect the asymptotic rate of responding. On the whole, these results show that cannabinoids do not exhibit reinforcing properties on the intracranial self-stimulation paradigm. On the contrary, in high doses they have an inhibiting effect on reward mechanisms. Furthermore, the acute administration of CB1 receptor agonists (WIN 55,212-2) and endocannabinoid modulators (AM-404) either decrease or do not affect locomotor activity. Except for the continuous dispute of the last decades considering the possible reinforcing effects of cannabinoids, it’s worth noting that multiple studies in basic level have shown an interaction of the endogenous cannabinoid system and the rewarding effects of other drugs of abuse, such as opioids, alcohol and nicotine. However, the interactions between cannabinoids and psychostimulants and, more specifically, cocaine have not been intensively studied and, those that have seem to be different from the ones of cannabinoids with other abused drugs. Considering all the above, another important goal of this study was the investigation of the interactions between agonists or modulators of the endogenous cannabinoids and cocaine, as far as it concerns the rewarding effects of cocaine and its stimulatory actions in locomotor behaviour. The results of this study clearly show that acute administration of CB1 receptor agonists (WIN 55,212-2) and endocannabinoid modulators (AM-404) does not affect the rewarding efficacy of the brain self-stimulation, but it decreases the rewarding effects of cocaine on the intracranial self-stimulation paradigm. These results show that cannabinoids may interact with the brain reward system which is responsible for the expression of the acute rewarding effects of drugs of abuse, such as cocaine, and that the endogenous cannabinoid system can serve as a new drug target for the treatment of addiction. Moreover, this study shows that the acute administration of CB1 receptor agonists (WIN 55,212-2) and endocannabinoid modulators (AM-404), even in high doses, does not affect locomotor activity, but it reduces the cocaine-induced hyperlocomotion, an action which is probably mediated through CB1 receptor stimulation. The fact that cannabinoids affect the hyperlocomotor activity of psychostimulants, like cocaine, lead us to positively think that they could be used as therapeutic agents for the treatment of neurological diseases which affect locomotion or even as a symptomatic therapy for the treatment of the psychomotor actions of addictive drugs. In conclusion, these results can change our view on the possible addictive effects and the therapeutic actions of cannabinoids. The possible therapeutic applications of Δ9-THC or its synthetic analogues which directly stimulate the CB1 receptors are reduced due to their various psychotropic effects they certainly have. Because of this, further experimental studies are required, based on new substances that indirectly stimulate CB1 receptors, by increasing, for example, the endogenous cannabinoid levels. These substances can be used as therapeutic targets for the development of new drugs. The results of this study contribute to and call for the increase in intensive research that aims in this direction.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2006

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Βλάχου, Στυλιανή
  • Vlachou, Styliani

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/15061

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Βλάχου, Στυλιανή; Vlachou, Styliani. Ο ρόλος του ενδογενούς συστήματος των κανναβινοειδών στη συμπεριφορά και στους μηχανισμούς ανταμοιβής: πειραματική μελέτη σε επιμύες. University of Crete (UOC), 2006. http://hdl.handle.net/10442/hedi/15061